3-Methylcytidine is a urinary nucleoside that can serve as a biomarker for four types of cancer, including lung cancer, gastric cancer, colon cancer, and breast cancer. Studies have shown it to be significantly upregulated in the urine samples of breast cancer patients, indicating its potential utility in diagnostic applications.
- Biomarker for lung, gastric, colon, and breast cancers
- Upregulated in urine samples of breast cancer patients
- Urinary nucleoside